| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11060-010-0331-5 |
| P698 | PubMed publication ID | 20734219 |
| P50 | author | Michel Kalamarides | Q89208459 |
| Matthieu Peyre | Q91073616 | ||
| P2093 | author name string | Marco Giovannini | |
| P2860 | cites work | Calcium channel antagonists inhibit growth of subcutaneous xenograft meningiomas in nude mice | Q43715291 |
| Prognostic value of allelic losses and telomerase activity in meningiomas | Q47732231 | ||
| Primary leptomeningeal meningiomatosis with widespread whorl formation | Q47966932 | ||
| Telomerase in intracranial meningiomas. | Q48147697 | ||
| Meningeal meningiomatosis in a child: case report | Q48158696 | ||
| Loss of merlin expression in sporadic meningiomas, ependymomas and schwannomas | Q48672251 | ||
| Prostaglandin D synthase (beta-trace) in meningeal hemangiopericytoma | Q48942301 | ||
| Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice | Q68965982 | ||
| Implantation of human meningiomas into the subrenal capsule of the nude mouse. A model for studies of tumor growth | Q69104675 | ||
| Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases | Q73193827 | ||
| Telomerase activity in ordinary meningiomas predicts poor outcome | Q73227576 | ||
| Matrigel augments xenograft transplantation of meningioma cells into athymic mice | Q74090334 | ||
| Establishment of primary human meningiomas as subcutaneous xenografts in mice | Q74616981 | ||
| Celecoxib inhibits meningioma tumor growth in a mouse xenograft model | Q79440234 | ||
| Prostaglandin D synthase (beta-trace) in human arachnoid and meningioma cells: roles as a cell marker or in cerebrospinal fluid absorption, tumorigenesis, and calcification process | Q24336624 | ||
| Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. | Q28507503 | ||
| Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors | Q28510087 | ||
| Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells | Q29614545 | ||
| A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity | Q30495392 | ||
| Temozolomide for treatment-resistant recurrent meningioma | Q33360388 | ||
| Tumors of the nervous system in carcinogenic hazard identification | Q33834825 | ||
| Chromosome engineering in mice | Q34290413 | ||
| Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features | Q34674321 | ||
| The treatment of malignant meningioma with verotoxin | Q34929060 | ||
| Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas | Q35747010 | ||
| Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse | Q35776239 | ||
| Xenotransplantation of a human meningioma and its lung metastasis in nude mice | Q36041955 | ||
| Insights into meningioangiomatosis with and without meningioma: a clinicopathologic and genetic series of 24 cases with review of the literature | Q36075465 | ||
| Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations | Q36477494 | ||
| N-ethyl-N-nitrosourea (ENU)-induced meningiomatosis and meningioma in p16(INK4a)/p19(ARF) tumor suppressor gene-deficient mice | Q36631828 | ||
| Molecular genetics of meningiomas: from basic research to potential clinical applications | Q36802280 | ||
| Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation | Q37368850 | ||
| The hTERT-protein and Ki-67 labelling index in recurrent and non-recurrent meningiomas. | Q38444202 | ||
| A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas | Q38456984 | ||
| Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice | Q39560555 | ||
| A comparison of the cell lines used in meningioma research | Q40015055 | ||
| A novel model of intracranial meningioma in mice using luciferase-expressing meningioma cells. Laboratory investigation | Q40018010 | ||
| An orthotopic skull base model of malignant meningioma. | Q40033241 | ||
| Heterotransplantation of Human Glioblastoma Multiforme and Meningioma to Nude Mice | Q40068725 | ||
| Establishment of an in vivo meningioma model with human telomerase reverse transcriptase | Q40148486 | ||
| Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas | Q40157832 | ||
| A genetic strategy to overcome the senescence of primary meningioma cell cultures | Q40300855 | ||
| Establishment of a benign meningioma cell line by hTERT-mediated immortalization | Q40407353 | ||
| Imaging of murine brain tumors using a 1.5 Tesla clinical MRI system. | Q40608054 | ||
| Intracranial injection of human meningioma cells in athymic mice: an orthotopic model for meningioma growth | Q40902186 | ||
| Evidence for multiple pathways to cellular senescence. | Q41418473 | ||
| Characterization of a newly established malignant meningioma cell line of the human brain: IOMM-Lee | Q41722619 | ||
| Cerebral meningioangiomatosis in a CD-1 mouse: a case report and comparison with humans and dogs | Q42437011 | ||
| Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. | Q42805196 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 325-331 | |
| P577 | publication date | 2010-08-24 | |
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | Meningioma mouse models | |
| P478 | volume | 99 |
| Q47570520 | Acute experimental Trypanosoma cruzi infection: establishing a murine model that utilises non-invasive measurements of disease parameters |
| Q41977858 | An Algorithm for the Preclinical Screening of Anticancer Drugs Effective against Brain Tumors. |
| Q52764536 | KLF4 is a tumor suppressor in anaplastic meningioma stem-like cells and human meningiomas. |
| Q38572601 | Malignant progression to anaplastic meningioma: Neuropathology, molecular pathology, and experimental models |
| Q99616661 | Multiplatform genomic profiling and magnetic resonance imaging identify mechanisms underlying intratumor heterogeneity in meningioma |
| Q36189820 | Role of Merlin/NF2 inactivation in tumor biology |
Search more.